Comparison Between Intravenous and Intramuscular Octreotide in the Management of Heyde's Syndrome.
Cureus
; 14(5): e25461, 2022 May.
Article
en En
| MEDLINE
| ID: mdl-35783893
ABSTRACT
Heyde's syndrome is defined as a triad of aortic stenosis, anemia due to angiodysplasia-related bleeding, and von Willebrand syndrome type 2A. It is a rare disease and a diagnostic challenge. Treatment modalities include symptomatic management, blood transfusions, aortic valve replacement, and medications such as octreotide. Here, we report the case of a patient who was resistant to symptomatic management, aortic valve replacement, as well as intravenous octreotide.
Texto completo:
1
Banco de datos:
MEDLINE
Idioma:
En
Año:
2022
Tipo del documento:
Article